系统生物学和体工程,以克服口服的吸收障碍:剂型优化案例研究,临床翻译之前
Puneet Tyagi1, Chandresh Patel1, Kimberly Gibson2
1Dosage Form Design and Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
Pharmaceutics
|October 28, 2023
概括
开发像MEDI7219这样的口服配方与透增强剂 (二氧化和甲酸) 在狗中实现了显著的口服生物可用性,为注射提供了潜在的替代品.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 口服酸面临着诸如低生物可用性和高可变性等挑战.
- 梅迪7219是一种稳定,脂化葡萄糖类1-激动性.
- 鉴定出基酸盐 (Na CDC) 和基酸盐 (PG) 是有效的透增强剂.
研究的目的:
- 开发和优化MEDI7219的口服药片配方.
- 为了评估不同型号的药片在狗体内体内的性能.
- 为了提高MEDI7219.9的口服生物利用性和减少药物动力学变异性.
主要方法:
- 立即释放片剂的配方包括Na CDC和PG.
- 在pH值≥5.5溶解的肠道涂层的应用,用于上部十二指肠向.
- 开发持续释放配方,使用 Carbopol 和在 pH ≥ 7.0 溶解的肠道涂层.
- 测试一种专有延迟释放侵蚀性屏障层平板电脑 (OralogiKTM).
- 在体内对狗进行的药理动力学研究.
主要成果:
- 优化的药片配方在狗中实现了MEDI7219绝对口服生物利用率高达10.1%.
- 对于MEDI7219,药物动力学变异性降低到26%的最低水平.
- 不同的配方策略显示出不同的释放特征和吸收特征.
结论:
- 成功开发了MEDI7219的口服药片配方,提高了生物可用性和降低了变异性.
- 优化的配方显示出对临床开发的希望,作为注射的替代品.
- 使用先进的涂层技术向胃肠道提供向的输送对于的口服输送至关重要.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
209
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
209
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Factors Influencing Drug Absorption: Presystemic Elimination
238
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
238
Factors Influencing Drug Absorption: Physicochemical Parameters
303
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
303
Factors Influencing Drug Absorption: Drug Dissolution
531
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
531
Drug Delivery: Enteral Route
468
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
468


